Metropolis Healthcare Ltd
METROPOLIS
Company Profile
Business description
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.
Contact
Dr. Annie Besant Road
4th Floor, East Wing
Plot-254 B, Nirlon House
Worli
MumbaiMH400 030
INDT: +91 8422801801
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2025
Employees
4,741
Stocks News & Analysis
stocks
Potential moonshot investment at ASX tech leader
Investors may be over optimistic about the prospects for a new revenue source.
stocks
These ASX earnings season dogs may have fallen too far
The longer term outlook for these moated companies looks far brighter than markets seem to be giving them credit for.
stocks
Our view of the supermarkets after earnings
Are the shares of two of Australia’s best known brands attractive?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,478.80 | 74.90 | 0.89% |
| CAC 40 | 8,229.57 | 117.94 | 1.45% |
| DAX 40 | 23,111.89 | 560.46 | 2.49% |
| Dow JONES (US) | 43,840.91 | 601.41 | 1.39% |
| FTSE 100 | 8,884.13 | 74.39 | 0.84% |
| HKSE | 23,006.27 | 64.95 | 0.28% |
| NASDAQ | 18,847.28 | 302.86 | 1.63% |
| Nikkei 225 | 37,785.47 | 629.97 | 1.70% |
| NZX 50 Index | 12,550.05 | 51.37 | -0.41% |
| S&P 500 | 5,954.50 | 92.93 | 1.59% |
| S&P/ASX 200 | 8,245.70 | 73.30 | 0.90% |
| SSE Composite Index | 3,316.93 | 3.97 | -0.12% |